CMD Intelligence helps long-duration capital understand which biomedical advances are real, which will translate, and what they could change across health systems, insurance and demographic risk. We combine scientific expertise with ecosystem intelligence to distinguish scientific novelty from durable consequence; making emerging scientific and institutional trajectories legible enough for better judgement.